loading...

Sheehan - Suicidality Tracking Scale (S-STS)

Sheehan DV; Coric V

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2009; Also named (Sheehan-STS).

It was adapted from the Suicidality Module of the Mini International Neuropsychiatric Interview (MINI) Structured Diagnostic Interview for DSM-IV developed in 1998 by Sheehan et al.

Authors

Sheehan DV; Coric V

Copyright
© Copyright Sheehan DV 2005-2014. All rights reserved.
Objective
The Sheehan – Suicidality Tracking Scale (S-STS) is a short scale designed to assess and monitor over time the core phenomena of suicidality. The same version can be used either as a clinician-rated scale or as a patient-rated scale, or both together at the same visit. The standard version was designed for use in clinical research studies as a safety assessment measure, to detect treatment emergent suicidality, and as a treatment outcome measure that is very sensitive to change. The S-STS is available in 3 age-related, linguistically validated pediatric versions (for 6 to 8 years old, for 9 to 12 years old, and for 13 to 17 years old).
The more expanded S-STS Clinically Meaningful Change Measure version (S-STS CMCM) addresses the needs of those who want to do a more comprehensive suicidality assessment clinically or who want a more comprehensive primary outcome measure when investigating the anti-suicidality treatment effects of medications. The S-STS CMCM is available in both adult and adolescent versions.
Therapeutic area
  • Behavior and Behavior Mechanisms
Therapeutic indication

Suicide Ideation

Type of Clinical Outcome Assessment (COA)
  • clinro ClinRO
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Coric V, Stock EG, Pultz J, Marcus R, Sheehan DV. Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder. Psychiatry (Edgmont). 2009 Jan;6(1):26-31 (Full Text Article)

Sheehan DV, Giddens JM, Sheehan IS. Status Update on the Sheehan-Suicidality Tracking Scale (S-STS) 2014. Innov Clin Neurosci. 2014 Sep;11(9-10):93-140 (Full Text article)

Access this questionnaire

Licensing

1. Paper/PDF versions

Any use of the paper/PDF versions of Dr David Sheehan's instruments must first be licensed by Dr David Sheehan.
A License Agreement must be signed beforehand by all users with Dr Sheehan and fees may be requested.
The original English versions of Dr David Sheehan's instruments are distributed exclusively by Dr Sheehan.

To speed up the licensing process with Dr Sheehan, all users are strongly advised to:

-          First go to Dr David Sheehan’s website (www.davidvsheehan.org), click on the relevant COA needed, click on “License Agreements for Use of COA”, and download the appropriate COA license agreement template as well as any other documents detailing the instructions to properly complete the license agreement.

-          N.B.: there are two types of license agreement: A license for the “Paper / PDF Version for Use in a Research Study or in a Healthcare Setting”, and a license for “exceptions that are granted a “no charge” license fee”.

-          Complete the appropriate license agreement and forward it to Dr David Sheehan (davidvsheehan@gmail.com).

-          Please note that partially completed licenses or licenses completed without following the instructions will either be rejected or not handled in priority by Dr Sheehan.

2. Electronic versions
 
For licensing or permissions to use any computerized or mobile device versions and applications of Dr David Sheehan's instruments, contact Nview directly at cmartin@nviewhealth.com. Fees may be requested.

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Fees may apply to your project.


Contact and conditions of use

Authors

Sheehan DV; Coric V

Distinguished University Health Professor Emeritus David V Sheehan M.D., M.B.A.
University of South Florida College of Medicine
Tampa, FL
USA
E-mail: davidvsheehan@gmail.com

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Licensing

1. Paper/PDF versions

Any use of the paper/PDF versions of Dr David Sheehan's instruments must first be licensed by Dr David Sheehan.
A License Agreement must be signed beforehand by all users with Dr Sheehan and fees may be requested.
The original English versions of Dr David Sheehan's instruments are distributed exclusively by Dr Sheehan.

To speed up the licensing process with Dr Sheehan, all users are strongly advised to:

-          First go to Dr David Sheehan’s website (www.davidvsheehan.org), click on the relevant COA needed, click on “License Agreements for Use of COA”, and download the appropriate COA license agreement template as well as any other documents detailing the instructions to properly complete the license agreement.

-          N.B.: there are two types of license agreement: A license for the “Paper / PDF Version for Use in a Research Study or in a Healthcare Setting”, and a license for “exceptions that are granted a “no charge” license fee”.

-          Complete the appropriate license agreement and forward it to Dr David Sheehan (davidvsheehan@gmail.com).

-          Please note that partially completed licenses or licenses completed without following the instructions will either be rejected or not handled in priority by Dr Sheehan.

2. Electronic versions
 
For licensing or permissions to use any computerized or mobile device versions and applications of Dr David Sheehan's instruments, contact Nview directly at cmartin@nviewhealth.com. Fees may be requested.

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Fees may apply to your project.

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Review copy available here

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

S-STS (Adult)

Afrikaans for South Africa*
English for Australia*
English for South Africa***
English for the UK***
Finnish for Finland*
French for Canada*
French for France*
German for Germany*
Gujarati for India*
Hungarian for Hungary***
Italian for Italy***
Japanese for Japan***
Mandarin for Singapore*
Marathi for India*
Russian for Russia*
Sesotho for South Africa*
Spanish for Chile***
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Tamil for Singapore*
Xhosa for South Africa*
Zulu for South Africa*

S-STS (Pediatric)

Bulgarian for Bulgaria*
Cebuano for the Philippines*
Croatian for Croatia*
Czech for Czech Republic*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for France*
German for Austria*
Greek for Greece*
Gujarati for India*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Kannada for India*
Korean for Korea*
Lithuanian for Lithuania*
Malay for Malaysia*
Malay for Singapore*
Malayalam for India*
Mandarin for Malaysia*
Mandarin for Singapore*
Marathi for India*
Polish for Poland*
Romanian for Romania*
Russian for Estonia*
Russian for Lithuania*
Swedish for Finland*
Swedish for Sweden*
Tagalog for the Philippines*
Turkish for Turkey*
* Performed by Mapi
*** Under development by Mapi

These translations may not be based on the latest S-STS version and may not be available for all the time recall versions ; further work may be needed before use.
Using the S-STS in English in non-English speaking countries is not allowed by Prof Sheehan. Country specific translations should be used.

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

1. Paper/PDF versions

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services.

2. Electronic versions

NView is the exclusive company authorized to implement electronic versions of Dr Sheehan’s scales. Any user interested in accessing electronic versions of Dr Sheehan’s scales’ translations shall contact Nview directly at cmartin@nviewhealth.com.

Academic Translation

If you wish to translate the questionnaire:

  1. Obtain written authorization from David V Sheehan
  2. Log in or Register for free
  3. Submit your request for translation online (Tutorials are available on our FAQs)
  4. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us